Market Overview:

The global veterinary imaging market reached a value of US$ 1.66 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 2.43 Billion by 2027, exhibiting a growth rate (CAGR) of 6.30% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Veterinary imaging is a non-invasive means of identifying and monitoring diseases and injuries among animals. It relies on X-radiation (ray) imaging/radiography, ultrasonography, computed tomography (CT), magnetic resonance imaging (MRI), and nuclear medicine imaging. It helps establish a standard database of normal anatomical, physiological, and functional parameters that can be used for clinical and research purposes. At present, there is a widespread prevalence of cardiovascular diseases (CVDs) among animals, which is catalyzing the demand for veterinary imaging across the globe.

Veterinary Imaging Market Trends:

At present, there is a considerable increase in the number of pet parents around the world. This, in confluence with rising expenditures on pet health and insurance, represents one of the key factors propelling the growth of the market. Moreover, radiography represents one of the commonly used imaging procedures in veterinary practices as it assists in creating images of bones, foreign objects, and large body cavities and detecting fractures, tumors, injuries, infections, and deformities. This, coupled with the rising number of dogs with orthopedic disorders, is positively influencing the market. Additionally, livestock diseases lead to productivity losses, uncertain food security, loss of income, and negative impacts on human health. As a result, the demand for veterinary imaging is rising around the world. Apart from this, advancements in veterinary MRI technology are enabling the scanning of soft tissue structures before surgery. This, along with the rapid expansion of veterinary hospitals worldwide and the increasing development of portable and battery-powered imaging instruments for point-of-care services, is driving the market. Furthermore, the rising focus on one health approach, which recognizes that the health of humans, animals, and ecosystems are interconnected, is fueling the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global veterinary imaging market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product type, animal type, application and end user.

Breakup by Product Type:

• Instrument
• Reagents
• Others
   

Breakup by Animal Type:

• Small Companion Animals
• Large Animals
   

Breakup by Application:

• Orthopedics and Traumatology
• Oncology
• Cardiology
• Neurology
• Others
   

Breakup by End User:

• Hospitals and Clinics
• Reference Laboratories
• Others
   

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Agfa-Gevaert N.V. (IG Farben), Canon Inc., Carestream Health Inc., Draminski S.A., Esaote SpA, Fujifilm holdings corp., Hallmarq Veterinary Imaging, Heska Corporation, IDEXX Laboratories Inc., IMV Technologies Group, MinXray Inc. and Siemens Healthineers AG (Siemens AG).

Report Coverage: